ANALYSIS OF SECRETORY PROTEINASES AND THEIR INHIBITORS INVOLED IN MYOBLAST DIFFERENTIATION USING SERUM-FREE CULTURE SYSTEM

无血清培养系统分析成肌细胞分化中的分泌蛋白酶及其抑制剂

基本信息

  • 批准号:
    11680705
  • 负责人:
  • 金额:
    $ 2.11万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2001
  • 项目状态:
    已结题

项目摘要

For the detailed investigation of extracellular signaling mechanism on the mammalian myoblasts differentiation, in vitro serum-free culture system was needed. To establish it, several kinds of media and supplements were tested and their concentrations were compared. As the result, we established serum-free culture conditions for myoblasts differentiation and the system provides reproducible results and induces myogenesis more efficiently than the previously reported ones with low serum concentration.To detect and characterize extracellular matrix (ECM) processing proteinases, we tried to improve ''zymography". Serine proteinases and metalloproteinases are known to be involved in the ECM processing. To optimize the conditions for two kinds of enzymes, buffer pII, components and their concentrations were examined. As the results, under the improved conditions metalloproteinases and serine proteinases were detected more sensitive by five-fold and two-fold, respectively, than the previously reported ones.Using improved culture conditions and detection methods, secretory proteinases were detected to vary during myoblasts differentiation. By the addition of proteinous inhibitors for serine proteinases and metalloproteinases, myogenesis were blocked. It demonstrated that the secretory proteinases may play critical roles in myogenesis and may affect in an autocrine manner. Previous reports demonstrated membrane type metalloproteinases family, ADAM play important roles in myogenesis. However, in our system in the presence,of synthetic inhibitor for meltrin, myogenesis was not blocked and it revealed that the contribution of ADAM may not play as a primary actors in the differentiation process.
为了深入研究细胞外信号对哺乳动物成肌细胞分化的影响,需要体外无血清培养体系。为了建立它,测试了几种培养基和补充剂并比较了它们的浓度。因此,我们建立了成肌细胞分化的无血清培养条件,该系统提供了可重复的结果,并且比以前报道的低血清浓度更有效地诱导成肌细胞。为了检测和表征细胞外基质(ECM)加工蛋白酶,我们试图改进“酶谱法”。已知丝氨酸蛋白酶和金属蛋白酶参与ECM加工。为了优化两种酶的条件,缓冲液pII,组分和它们的浓度进行了检查。结果表明,在改进的培养条件下,金属蛋白酶和丝氨酸蛋白酶的检测灵敏度分别提高了5倍和2倍。通过添加丝氨酸蛋白酶和金属蛋白酶的蛋白质抑制剂,肌生成被阻断。这表明分泌性蛋白酶可能在肌肉发生中起关键作用,并可能以自分泌方式起作用。以往的研究表明膜型金属蛋白酶家族ADAM在肌形成过程中起重要作用。然而,在我们的系统中,在meltrin的合成抑制剂的存在下,肌生成没有被阻断,并且它揭示了ADAM的贡献可能不是分化过程中的主要参与者。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
安光英太郎: "改訂 蛋白質実験ノート(上)"羊土社. 44 (1999)
安光英太郎:“蛋白质实验笔记修订版(第 1 部分)”Yodosha。44(1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Miyata, S., et al.: "Expression of trypsin in human cancer cell lines and cancer tissues, and its tight binding to soluble form of Alzheimer amyloid precursor protein in culture"Journal of Biochemistry. 125. 1067-1076 (1999)
Miyata, S.等人:“胰蛋白酶在人类癌细胞系和癌症组织中的表达,及其与培养物中可溶形式的阿尔茨海默淀粉样前体蛋白的紧密结合”《生物化学杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
宮崎香他: "最新電気泳動実験法"医歯薬出版. 7 (1999)
Kaoru Miyazaki 等:“最新电泳实验方法”石药出版 7 (1999)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Miyata, S., et al.: "Trypsin stimulates integrin alpha (5) beta (1)-dependent adhesion to fibronectin and proliferation of human gastric carcinom a cells through activation of proteinase-activated receptor-2"J. Biol. Chem.. 275. 4592-4598 (2000)
Miyata, S., et al.:“胰蛋白酶通过激活蛋白酶激活受体 2 来刺激整合素 α (5) beta (1) 依赖的纤连蛋白粘附和人胃癌细胞的增殖”J.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YASUMITSU Hidetaro其他文献

YASUMITSU Hidetaro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YASUMITSU Hidetaro', 18)}}的其他基金

Proteinase secretion in serum-independent cell lines established from human cancer cell lines.
由人类癌细胞系建立的不依赖于血清的细胞系中的蛋白酶分泌。
  • 批准号:
    06672188
  • 财政年份:
    1994
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Regenerating Vascularized and Innervated Skeletal Muscle to Treat VML Defects
再生血管化和神经支配的骨骼肌来治疗 VML 缺陷
  • 批准号:
    10748834
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
Molecular Mechanisms of Myoblast Fusion
成肌细胞融合的分子机制
  • 批准号:
    10928438
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
2023 Eye Movements GRC & GRS
2023眼动GRC
  • 批准号:
    10601221
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
Lysosomal TRPML Channels in Myogenesis and Centronuclear Myopathies
肌发生和中心核肌病中的溶酶体 TRPML 通道
  • 批准号:
    488716
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Operating Grants
The role of Fbxl22 in the regulation of skeletal muscle mass
Fbxl22在骨骼肌质量调节中的作用
  • 批准号:
    10831254
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
2023 Myogenesis GRC & GRS
2023 肌生成GRC
  • 批准号:
    10602984
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
Mineral Coated Microparticles for Stabilization and Delivery of Complexed mRNA for Healing of Long Bone Defects
用于稳定和递送复合 mRNA 的矿物涂层微粒,用于治疗长骨缺损
  • 批准号:
    10464358
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
N6-Methyladenosine Methylome in Duchenne Muscular Dystrophy
N6-甲基腺苷甲基化在杜氏肌营养不良症中的应用
  • 批准号:
    10593310
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
Mapping the non-coding RNA landscape in skeletal muscle health and disease
绘制骨骼肌健康和疾病中非编码 RNA 的图谱
  • 批准号:
    10666261
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
Novel mechanisms of muscle and bone loss with HIV infection, antiretroviral therapy, and aging.
HIV 感染、抗逆转录病毒治疗和衰老导致肌肉和骨质流失的新机制。
  • 批准号:
    10696502
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了